Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Sarsasapogenin

EU orphan designation number: EU/3/08/543
Active ingredient: Sarsasapogenin
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Phytopharm plc
Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambridgeshire PE29 6UA, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/05/2008 Centralised Orphan - Designation EMEA/OD/125/07 (2008)1883 of 08/05/2008
05/11/2010 Other procedure EMA/444022/2010
27/07/2012 Centralised Orphan - Removal of orphan designation from Community Register